162 related articles for article (PubMed ID: 36066420)
1. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
[TBL] [Abstract][Full Text] [Related]
2. Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication.
Xiao RW; Wang F; Wang TM; Zhang JB; Wu ZY; Deng CM; Liao Y; Zhou T; Yang DW; Dong SQ; Xue WQ; He YQ; Zheng XH; Li XZ; Zhang PF; Zhang SD; Hu YZ; Liu YY; Xia YF; Gao S; Mu JB; Feng L; Jia WH
EBioMedicine; 2022 Oct; 84():104267. PubMed ID: 36116213
[TBL] [Abstract][Full Text] [Related]
3. Genomic landscape of Epstein-Barr virus in familial nasopharyngeal carcinoma.
Zhang WL; Zhang JB; Wang TM; Wu YX; He YQ; Xue WQ; Liao Y; Deng CM; Li DH; Wu ZY; Yang DW; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Jia WH
J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35349400
[TBL] [Abstract][Full Text] [Related]
4. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.
Yu G; Hsu WL; Coghill AE; Yu KJ; Wang CP; Lou PJ; Liu Z; Jones K; Vogt A; Wang M; Mbulaiteye SM; Chen HH; Boland J; Yeager M; Diehl SR; Chen CJ; Hildesheim A; Goldstein AM
Sci Rep; 2019 Jul; 9(1):9916. PubMed ID: 31289279
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC.
Liu Z; Goldstein AM; Hsu WL; Yu KJ; Chien YC; Ko JY; Jian JJ; Tsou YA; Leu YS; Liao LJ; Chang YL; Wang CP; Wu JS; Hua CH; Lee JC; Yang TL; Hsiao CK; Wu MS; Tsai MH; Huang KK; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou PJ; Chen CJ; Hildesheim A;
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1682-1686. PubMed ID: 31270100
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.
Dai W; Zheng H; Cheung AK; Tang CS; Ko JM; Wong BW; Leong MM; Sham PC; Cheung F; Kwong DL; Ngan RK; Ng WT; Yau CC; Pan J; Peng X; Tung S; Zhang Z; Ji M; Chiang AK; Lee AW; Lee VH; Lam KO; Au KH; Cheng HC; Yiu HH; Lung ML
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3317-22. PubMed ID: 26951679
[TBL] [Abstract][Full Text] [Related]
8. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.
Xu M; Yao Y; Chen H; Zhang S; Cao SM; Zhang Z; Luo B; Liu Z; Li Z; Xiang T; He G; Feng QS; Chen LZ; Guo X; Jia WH; Chen MY; Zhang X; Xie SH; Peng R; Chang ET; Pedergnana V; Feng L; Bei JX; Xu RH; Zeng MS; Ye W; Adami HO; Lin X; Zhai W; Zeng YX; Liu J
Nat Genet; 2019 Jul; 51(7):1131-1136. PubMed ID: 31209392
[TBL] [Abstract][Full Text] [Related]
9. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
10. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.
Coghill AE; Hsu WL; Yang Q; Wang CP; Lou PJ; Yu KJ; Yu G; Diehl SR; Chen CJ; Goldstein AM; Hildesheim A
J Gen Virol; 2018 Sep; 99(9):1268-1273. PubMed ID: 29975184
[TBL] [Abstract][Full Text] [Related]
11. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
12. Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation.
Xu M; Feng R; Liu Z; Zhou X; Chen Y; Cao Y; Valeri L; Li Z; Liu Z; Cao SM; Liu Q; Xie SH; Chang ET; Jia WH; Shen J; Yao Y; Cai YL; Zheng Y; Zhang Z; Huang G; Ernberg I; Tang M; Ye W; Adami HO; Zeng YX; Lin X
Cell Genom; 2024 Feb; 4(2):100474. PubMed ID: 38359790
[TBL] [Abstract][Full Text] [Related]
13. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
14. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.
Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A
J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957
[TBL] [Abstract][Full Text] [Related]
16. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
Yu KJ; Hsu WL; Chiang CJ; Chen TC; Liu Z; Lou PJ; Diehl S; Goldstein AM; Chen CJ; Wang CP; Hildesheim A
Cancer; 2021 Nov; 127(22):4171-4176. PubMed ID: 34324707
[TBL] [Abstract][Full Text] [Related]
17. Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
Liu Z; Chang ET; Liu Q; Cai Y; Zhang Z; Chen G; Huang QH; Xie SH; Cao SM; Shao JY; Jia WH; Zheng Y; Liao J; Chen Y; Lin L; Liang L; Ernberg I; Vaughan TL; Adami HO; Huang G; Zeng Y; Zeng YX; Ye W
Cancer; 2017 Jul; 123(14):2716-2725. PubMed ID: 28241094
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
20. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]